Holen Sie sich die Stockscreener-App
4.21
0.47%
0.010
Handel nachbörslich:
4.34
0.13
+3.09%
Schlusskurs vom Vortag:
$4.22
Offen:
$4.2
24-Stunden-Volumen:
41,767
Relative Volume:
0.35
Marktkapitalisierung:
$2.87M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.27M
KGV:
-0.1966
EPS:
-21.4132
Netto-Cashflow:
$-9.40M
1W Leistung:
-5.36%
1M Leistung:
-21.55%
6M Leistung:
-47.62%
1J Leistung:
-67.13%
1-Tages-Spanne:
$4.11
$4.36
1-Wochen-Bereich:
$3.83
$5.18
52-Wochen-Spanne:
$3.83
$23.70
Dermata Therapeutics Inc Stock (DRMA) Company Profile
Firmenname
Dermata Therapeutics Inc
Sektor
Branche
Telefon
(858)-223-0882
Adresse
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
Vergleichen Sie DRMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DRMA
Dermata Therapeutics Inc
|
4.21 | 2.88M | 0 | -11.27M | -9.40M | -21.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Dermata Therapeutics Inc Aktie (DRMA) Neueste Nachrichten
Is Dermata Therapeutics Inc. Equity Warrant stock poised for growth2025 Year in Review & Free High Accuracy Swing Entry Alerts - newser.com
Analyzing drawdowns of Dermata Therapeutics Inc. with statistical toolsMarket Risk Summary & Community Consensus Picks - newser.com
Risk vs reward if holding onto Dermata Therapeutics Inc. Equity WarrantBreakout Watch & Advanced Swing Trade Entry Plans - newser.com
Can Expleo Solutions Limited Survive Disruption in Its Core IndustryREITs Market Trends & Build Your Portfolio With Our Free Stock Scanner - earlytimes.in
How buybacks impact Dermata Therapeutics Inc. Equity Warrant stock valueJuly 2025 Technicals & Fast Exit and Entry Trade Guides - newser.com
Applying Elliott Wave Theory to Dermata Therapeutics Inc.Trade Signal Summary & Free Fast Gain Swing Trade Alerts - newser.com
What valuation multiples suggest for Dermata Therapeutics Inc. Equity Warrant stockMarket Activity Recap & Daily Volume Surge Signals - newser.com
Analyzing Dermata Therapeutics Inc. Equity Warrant with risk reward ratio chartsWeekly Profit Recap & Verified High Yield Trade Plans - newser.com
Why Dermata Therapeutics Inc. stock could outperform in 2025Weekly Investment Recap & Entry Point Confirmation Signals - newser.com
Advanced analytics toolkit walkthrough for Dermata Therapeutics Inc. Equity Warrant2025 Geopolitical Influence & Intraday High Probability Alerts - newser.com
Momentum divergence signals in Dermata Therapeutics Inc. Equity Warrant chartEarnings Recap Report & Fast Moving Stock Watchlists - newser.com
How to monitor Dermata Therapeutics Inc. Equity Warrant with trend dashboardsJuly 2025 PostEarnings & Free Weekly Chart Analysis and Trade Guides - newser.com
Developing predictive dashboards with Dermata Therapeutics Inc. dataJuly 2025 Earnings & Fast Moving Stock Watchlists - newser.com
Pattern recognition hints at Dermata Therapeutics Inc. upsideWeekly Trade Analysis & Accurate Buy Signal Alerts - newser.com
Historical volatility pattern of Dermata Therapeutics Inc. visualizedPortfolio Update Report & Weekly High Conviction Trade Ideas - newser.com
Dermata Therapeutics announces $2.55M private offering - MSN
Short interest data insights for Dermata Therapeutics Inc. Equity WarrantJuly 2025 PostEarnings & Technical Confirmation Alerts - newser.com
Using R and stats models for Dermata Therapeutics Inc. forecastingJuly 2025 Outlook & Short-Term High Return Ideas - newser.com
Analyzing drawdowns of Dermata Therapeutics Inc. Equity Warrant with statistical tools2025 Risk Factors & Reliable Breakout Forecasts - newser.com
Technical analysis overview for Dermata Therapeutics Inc. Equity Warrant stock2025 Support & Resistance & Long-Term Safe Return Strategies - newser.com
Does Dermata Therapeutics Inc. qualify in momentum factor screeningMarket Risk Analysis & Weekly High Potential Alerts - newser.com
Why Dermata Therapeutics Inc. stock remains a top recommendationJuly 2025 Outlook & AI Powered Trade Plan Recommendations - newser.com
Will Dermata Therapeutics Inc. Equity Warrant price bounce be sustainableEarnings Growth Summary & Real-Time Chart Breakout Alerts - newser.com
What drives Dermata Therapeutics Inc stock priceMarket Correction Analysis & Low Risk Investment Tips - earlytimes.in
Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket - Benzinga
News impact scoring models applied to Dermata Therapeutics Inc. Equity Warrant2025 Price Momentum & Smart Money Movement Tracker - newser.com
What the charts say about Dermata Therapeutics Inc. Equity Warrant today2025 Fundamental Recap & Smart Allocation Stock Tips - newser.com
Is Dermata Therapeutics Inc. Equity Warrant stock a top pick in earnings seasonMarket Sentiment Report & Community Verified Trade Alerts - newser.com
Why Dermata Therapeutics Inc. Equity Warrant stock is a must watch in 2025Market Growth Summary & Real-Time Chart Breakout Alerts - newser.com
Measuring Dermata Therapeutics Inc. Equity Warrant’s beta against major indicesJuly 2025 Outlook & Weekly High Return Stock Opportunities - newser.com
What momentum shifts mean for Dermata Therapeutics Inc. Equity WarrantWeekly Trade Analysis & Consistent Profit Trade Alerts - newser.com
Psyence Biomedical Stock Price, Quotes and Forecasts | NASDAQ:PBM - Benzinga
Advanced analytics toolkit walkthrough for Dermata Therapeutics Inc.Long Setup & Weekly Setup with ROI Potential - newser.com
Australian patent office accepts Dermata’s acne treatment patent By Investing.com - Investing.com Canada
Australian patent office accepts Dermata’s acne treatment patent - Investing.com Australia
Finanzdaten der Dermata Therapeutics Inc-Aktie (DRMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):